We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/5/2018 11:52 | Romeike You don’t know what you are talking about! Do your research and come back. By then these will be double today’s price. | cudmore | |
18/5/2018 11:48 | Some sort of activity can't be far off especially as Invesco and Woodford can't be too happy!!! | joeblogg2 | |
18/5/2018 11:01 | Cudmore - the one man pump and dump army. This co. will come out with less than 15m. Not much interest from potential buyers. Computational biology the only part that is of interest but that swings from profit to loss each year, so cannot be stand alone. Talk about licensing out Txr, moxatag etc is dreamland stuff - no one is interested in these pointlessly expensive long duration pills with all the politics around high drug costs. No value here until that moron Garland leaves. | romeike | |
16/5/2018 12:40 | Anyone selling these at the moment should be strung up. The upside to these is massive!! Broker minimum forecast of 21p!! | cudmore | |
16/5/2018 06:54 | The management of Vernalis should be strung up by the balls for the destruction they have inflicted upon the business and its shareholder. Mismanagement doesn't even begin to describe their incompetence and stupidity On a NAV basis this stock is undervalued - pity about the management | gersemi | |
16/5/2018 06:38 | These are an early Xmas present at this price. 4 brokers staying between 21p-30p share price target. DYOR but read the facts and go where the cash goes. Healthinvest just grabbed 6% of the shares out there. Says it all really! | cudmore | |
15/5/2018 15:53 | something brewing....... | chrisdgb | |
15/5/2018 15:43 | Wow. Relentless buying here today! Pleased I am in although nowhere near the low sadly🙄. | nobbygnome | |
15/5/2018 15:27 | 7 trade.....RNS at 7.00am? 🤔 | cudmore | |
15/5/2018 15:23 | back to getting 5.11 to sell so maybe some action soon??? | joeblogg2 | |
15/5/2018 13:41 | now just getting 4.5p to sell 100k shrs so demand tailing off. | joeblogg2 | |
15/5/2018 13:37 | Broker tip at 22-30p!!!! | cudmore | |
15/5/2018 13:33 | Just sold added to the WEB drop.. Happy days | shirley83 | |
15/5/2018 13:18 | Been watching these for a few weeks. Think these could easily double from today’s price. Buy and hold under 5p if you can | cudmore | |
15/5/2018 13:13 | Let us hope the management can deliver a deal.. | chrisdgb | |
15/5/2018 12:41 | Getting 5.1p to sell now, so demand out there!!! | joeblogg2 | |
15/5/2018 12:38 | So these have 46m in cash ? What's the updated mkp | kirk 6 | |
15/5/2018 12:31 | Not sure if they are the cause of the buying but can sell my 100k shrs at 5p when at times could not even get a quote over the last week. | joeblogg2 | |
15/5/2018 12:21 | Topinfo' S ramp of the day on Twitter. | handykart | |
15/5/2018 11:51 | wish I knew but some sort of break up or reverse takeover will be only way to extract value and return for shareholders since decimation of share price!!!! | joeblogg2 | |
15/5/2018 11:44 | why up 26% today, hols from £2.00 | latifs100 | |
15/5/2018 11:33 | Looks like excitement over for time being as marked down now. | joeblogg2 | |
15/5/2018 11:33 | Pump and Dump - beware | romeike | |
15/5/2018 11:16 | Got to agree its worth more than 4/5p. But how much more? Think they can turn off the spending taps quite easily. Appallingly managed company-let's hope there is plenty of pressure being applied by institutions behind the scenes. | meijiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions